Lanoxin Pg (Digoxin)

Digoxin inhibits the Na+/K+ ATPase pump in heart muscle cells, leading to increased intracellular calcium. This boost in calcium enhances the strength of cardiac contractions, while its vagomimetic action slows conduction through the atrioventricular node, helping to control heart rate.

The appropriate dose of Lanoxin Pg is individualized by the prescribing clinician based on factors such as the patient’s age, kidney function, electrolyte status, and therapeutic drug‑monitoring results. No fixed regimen is provided here; the prescriber sets the dose.

Safety data for digoxin in pregnancy and lactation are limited. It is generally used only when the potential benefit outweighs potential risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Lanoxin Pg, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Unlike ACE inhibitors or beta‑blockers, digoxin primarily increases contractile force and provides rate‑control benefits in atrial arrhythmias. It is often added to standard therapy when additional symptom relief is needed, but it requires careful monitoring for toxicity, which is less of a concern with many other agents.

Store Lanoxin Pg at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Lanoxin Pg is taken orally, usually with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed.

The most critical risks include cardiac arrhythmias, severe bradycardia, heart block, and hyperkalemia, all of which can be life‑threatening. Prompt medical attention is required if patients experience palpitations, fainting, visual disturbances, or signs of toxicity.

Lanoxin Pg should be avoided in patients with known hypersensitivity to digoxin, uncontrolled ventricular arrhythmias, severe conduction disturbances without a pacemaker, and in those with significant renal impairment unless dose is appropriately adjusted and closely monitored.